158,617 Shares in Tilray Inc (NASDAQ:TLRY) Bought by Teacher Retirement System of Texas

Teacher Retirement System of Texas acquired a new position in Tilray Inc (NASDAQ:TLRY) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 158,617 shares of the company’s stock, valued at approximately $211,000.

Several other institutional investors have also bought and sold shares of the stock. Bank of Montreal Can boosted its holdings in Tilray by 0.3% during the third quarter. Bank of Montreal Can now owns 2,176,506 shares of the company’s stock worth $3,787,000 after buying an additional 7,406 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in Tilray by 4.9% during the third quarter. The Manufacturers Life Insurance Company now owns 715,672 shares of the company’s stock worth $1,260,000 after purchasing an additional 33,194 shares during the period. BNP Paribas Financial Markets boosted its holdings in Tilray by 1,314.1% during the third quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock valued at $3,202,000 after acquiring an additional 1,690,827 shares during the period. CreativeOne Wealth LLC acquired a new stake in Tilray in the 3rd quarter valued at approximately $127,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Tilray by 6.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,677,899 shares of the company’s stock valued at $2,953,000 after buying an additional 107,530 shares during the period. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Stock Performance

NASDAQ:TLRY opened at $0.65 on Thursday. The stock has a market capitalization of $609.48 million, a P/E ratio of -2.17 and a beta of 1.88. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. Tilray Inc has a 1 year low of $0.58 and a 1 year high of $2.97. The firm has a 50 day moving average of $0.82 and a 200-day moving average of $1.24.

Tilray (NASDAQ:TLRY) last issued its quarterly earnings data on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The business had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. As a group, sell-side analysts anticipate that Tilray Inc will post -0.2 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group lifted their price objective on Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a report on Monday, January 13th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $2.70.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.